Aranesp vs Neupogen

Aranesp
(Rx)
Neupogen
(Rx)
Aranesp is an link kb-display="Erythropoietins"erythropoietin/link.
Neupogen is a granulocyte Colony-Stimulating factor (G-CSF).
Satisfaction Score
?
3.8
Very Satisfied
Satisfaction Score
?
3.4
Moderately Satisfied
Concern level
1.5
Concern level
2.2
Approval Date
+ -
September 17, 2001
February 20, 1991
Number of discussions around the web Number of discussions + -
3,938 Discussions
27,583 Discussions
Taken For
+ -
Condition
Number of posts
Aranesp is prescribed for Anemia and Myelodysplastic Syndrome and is mostly mentioned together with these indications.
Condition
Number of posts
Neupogen is prescribed for Low WBC and Neutropenia and is mostly mentioned together with these indications. It is used in Transplant. In addition, our data suggest that Neupogen is taken for Myelodysplastic Syndrome, although it is not approved for this condition.
Side Effects and Concerns
+ -
Ara
Nausea
4
Bone Pain
3
Weakness
2
Blood Clots
2
Kidney Disease
2
Diabetes
1
Stroke
1
Depression
1
Heart Attack
1
Constipation
1
Neu
Bone Pain
10
Tiredness
9
Nausea
6
Fever
4
Anemia
4
Headaches
2
Hair Loss
2
Allergy
2
Neuropathy
2
Weakness
1
Compare concerns
By:
Aranesp
Ara
Neupogen
Neu
Nausea
Ara
Neu
4
6
Bone Pain
Ara
Neu
3
10
Weakness
Ara
Neu
2
1
Blood Clots
Ara
Neu
2
0
Kidney Disease
Ara
Neu
2
0
Diabetes
Ara
Neu
1
0
Stroke
Ara
Neu
1
0
Depression
Ara
Neu
1
0
Heart Attack
Ara
Neu
1
0
Constipation
Ara
Neu
1
0
Bone Pain
Neu
Ara
10
3
Tiredness
Neu
Ara
9
0
Nausea
Neu
Ara
6
4
Fever
Neu
Ara
4
0
Anemia
Neu
Ara
4
0
Headaches
Neu
Ara
2
0
Hair Loss
Neu
Ara
2
0
Allergy
Neu
Ara
2
0
Neuropathy
Neu
Ara
2
0
Weakness
Neu
Ara
1
2
Pregnancy Category (FDA) OpenClose all pregnancy categories
+ -
a b c d x n
Category A
Adequate and well-controllted studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
Category B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Category C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category D
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Category X
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.
Category N
FDA has not classified the drug.
close
C Category C
Before taking Aranesp during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
C Category C
Before taking Neupogen during pregnancy, consult your doctor or pharmacists to weigh the risks and benefits.
Alcohol warning
+ -
There may be a negative interaction between Aranesp and alcohol.
There may be a negative interaction between Neupogen and alcohol.
Method of use
+ -
Injection
Injection
Dosages
+ -
Syringe: 60 mcg/0.3 mL, 150 mcg/0.3 mL, 10 mcg/0.4 mL, 40 mcg/0.4 mL, 200 mcg/0.4 mL, 25 mcg/0.42 mL, 100 mcg/0.5 mL, 300 mcg/0.6 mL, 500 mcg/mL
Injector: 60 mcg/0.3 mL, 150 mcg/0.3 mL, 40 mcg/0.4 mL, 200 mcg/0.4 mL, 25 mcg/0.42 mL, 100 mcg/0.5 mL, 300 mcg/0.6 mL, 500 mcg/mL
Solution: 150 mcg/0.75 mL, 25 mcg/mL, 40 mcg/mL, 60 mcg/mL, 100 mcg/mL, 200 mcg/mL, 300 mcg/mL
Syringe: 300 mcg/0.5 mL, 300 mcg/0.5mL, 480 mcg/0.8 mL, 480 mcg/0.8mL
Solution: 480 mcg/1.6 mL, 300 mcg/mL
Food Instructions
+ -
No Food Instructions
No Food Instructions
Ingredients
+ -
Darbepoetin Alfa In Albumn Sol , Darbepoetin Alfa In Polysorbat
Filgrastim
Drug Interactions
+ -
Interaction between Aranesp and Neupogen: Interaction not known, but may still exist. Always consult your doctor before taking these medications together. Do not stop taking the medications without a physician's advice.
Read more about:
Aranesp
Read more about:
Neupogen
content loaded dynamically
Filter by
Filter by
Gender
Role
Age
All
We found 249 discussions
Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice.
The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you.
The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information.
Welcome back! Sign in
See what other patients are saying
First time here? Sign up!
See what other patients are saying
Forgot your password?
No problem, we can help.
Please wait...